BREAST CANCER DIAGNOSIS: MODERN METHODS, CLINICAL APPROACHES AND EARLY DETECTION STRATEGIES

Abstract

Breast cancer remains one of the most common malignancies affecting women globally, with early identification playing a critical role in improving survival rates and reducing the need for extensive treatments. This article examines contemporary diagnostic techniques, clinical evaluation methods, and strategies for prompt identification of the disease. Conventional imaging approaches such as mammography continue to serve as foundational tools, yet advancements including digital breast tomosynthesis, magnetic resonance imaging, and ultrasound have enhanced accuracy, particularly in women with dense breast tissue. Emerging technologies, including artificial intelligence applications in image analysis, biosensor platforms targeting specific biomarkers in blood, saliva, urine, sweat, and breath, as well as wearable devices like smart bras equipped with thermosensors and microwave imaging components, offer non-invasive, patient-friendly alternatives that support continuous monitoring and personalized risk assessment. Clinical approaches integrate physical examination, patient history review, and risk stratification based on genetic factors and family background to guide diagnostic pathways. Early detection programs emphasize population-based screening tailored to age groups and individual risk levels, incorporating multimodal strategies that combine traditional and innovative methods to minimize false positives and negatives while maximizing accessibility in diverse healthcare settings. Literature synthesis reveals that these integrated approaches can achieve detection sensitivities exceeding ninety percent in early stages, leading to survival rates approaching ninety percent for localized disease. Challenges persist in cost-effectiveness, standardization, and equitable access, especially in resource-limited regions. Future directions point toward hybrid systems that fuse artificial intelligence with biosensors and wearable technologies for real-time, precise diagnostics. This comprehensive review underscores the transformative potential of modern methods in shifting breast cancer management from reactive treatment to proactive, preventive care, ultimately contributing to reduced mortality and improved quality of life for affected individuals. The discussion highlights evidence from recent studies demonstrating superior performance of combined modalities over single techniques alone, with emphasis on clinical implementation and strategic frameworks for widespread adoption. Overall, the integration of these elements promises a paradigm shift in breast cancer care by the year two thousand thirty.